Shilajit/Fulvic Acid / selectivity Cancer Research Results

FulvicA, Shilajit/Fulvic Acid: Click to Expand ⟱
Features:
Fulvic acid is a naturally occurring compound found in soil, compost, and marine sediments. It is a complex mixture of many organic acids and has been studied for its antioxidant, anti-inflammatory, and immune-modulating properties.
Shilajit is a complex mineral–organic exudate found in mountainous regions (e.g., Himalayas). It contains fulvic acids, humic substances, dibenzo-α-pyrones (DBPs), trace minerals, and other low-molecular-weight compounds. Most standardized extracts are characterized by fulvic acid content (often 15–60%).

AD:
-Fulvic acid may help inhibit tau fibril formatio
-Antioxidant activity
-Anti-inflammatory effects

Cancer:
-Fulvic acid’s role in reducing drug resistance and improving drug absorption has been suggested
-Synergistic effects with chemotherapy

Fulvic Acid database results: Note how it is antioxidant for normal cells, but may produce ROS in cancer cells. (explains synergistic effect with chemo)
LeafSource Fulvic Acid note how they use Fulvic Acid to improve bioavailability of berberine.

Rank Pathway / Axis Cancer / Tumor Context Normal Tissue Context TSF Primary Effect Notes / Interpretation
1 Mitochondrial function / electron transport support Bioenergetic modulation (context-dependent) ATP production support ↑ (reported) P, R Mitochondrial optimization Dibenzo-α-pyrones and fulvic acids are reported to support mitochondrial respiration in non-cancer models.
2 Nrf2 / antioxidant response Redox tone modulation (model-dependent) Nrf2 ↑; antioxidant enzymes ↑ R, G Redox buffering Commonly described as antioxidant; tumor-direction effects are not well established.
3 NF-κB inflammatory signaling NF-κB ↓ (reported; limited cancer data) Inflammation tone ↓ R, G Anti-inflammatory modulation Anti-inflammatory effects are better documented than direct tumor cytotoxicity.
4 ROS modulation ROS ↓ or stabilized (context-dependent) Oxidative stress ↓ P, R, G Antioxidant effect Acts primarily as redox stabilizer rather than ROS generator.
5 AMPK / metabolic stress pathways Metabolic modulation (limited direct tumor evidence) Energy homeostasis support ↑ R, G Metabolic adaptation Some reports suggest improved metabolic efficiency; not a primary oncologic mechanism.
6 Cell-cycle / apoptosis Apoptosis ↑ (reported in limited preclinical studies) ↔ G Conditional cytotoxicity Data are sparse and largely cell-line based; not a strong, consistent cytotoxic signature.
7 Immune modulation Immune tone modulation (context-dependent) Immune support ↑ R, G Adaptogenic effect Traditional use emphasizes immune and vitality support rather than direct anticancer activity.
8 Metal chelation / mineral transport Trace mineral transport effects (uncertain tumor relevance) Mineral absorption modulation P Biochemical modulation Fulvic acid has chelation properties; relevance to oncology unclear.
9 Quality / contamination risk Variable depending on preparation Heavy metal exposure risk if unrefined — Safety constraint Crude shilajit may contain heavy metals; purified standardized extracts preferred.
10 Bioavailability variability Systemic exposure varies by extraction/purification — — Translation constraint Composition varies widely; standardization typically based on fulvic acid content.

Time-Scale Flag (TSF): P / R / G

  • P: 0–30 min (rapid mitochondrial/redox interactions)
  • R: 30 min–3 hr (acute signaling and metabolic shifts)
  • G: >3 hr (gene-regulatory adaptation and phenotype outcomes)
selectivity, selectivity: Click to Expand ⟱
Source:
Type:
The selectivity of cancer products (such as chemotherapeutic agents, targeted therapies, immunotherapies, and novel cancer drugs) refers to their ability to affect cancer cells preferentially over normal, healthy cells. High selectivity is important because it can lead to better patient outcomes by reducing side effects and minimizing damage to normal tissues.

Achieving high selectivity in cancer treatment is crucial for improving patient outcomes. It relies on pinpointing molecular differences between cancerous and normal cells, designing drugs or delivery systems that exploit these differences, and overcoming intrinsic challenges like tumor heterogeneity and resistance

Factors that affect selectivity:
1. Ability of Cancer cells to preferentially absorb a product/drug
-EPR-enhanced permeability and retention of cancer cells
-nanoparticle formations/carriers may target cancer cells over normal cells
-Liposomal formations. Also negatively/positively charged affects absorbtion

2. Product/drug effect may be different for normal vs cancer cells
- hypoxia
- transition metal content levels (iron/copper) change probability of fenton reaction.
- pH levels
- antiOxidant levels and defense levels

3. Bio-availability
Scientific Papers found: Click to Expand⟱
4023- FulvicA,    Shilajit (Mumio) Elicits Apoptosis and Suppresses Cell Migration in Oral Cancer Cells through Targeting Urokinase-type Plasminogen Activator and Its Receptor and Chemokine Signaling Pathways
- in-vitro, Oral, NA
tumCV↓, selectivity↑, Apoptosis↑, uPA↓, TumCMig↓, Dose↝, CXCc↓,
4025- FulvicA,    Mumio (Shilajit) as a potential chemotherapeutic for the urinary bladder cancer treatment
- in-vitro, Bladder, T24/HTB-9 - Review, AD, NA
tumCV↓, selectivity↑, TumCCA↑, other↝, *neuroP↑, *memory↑, *tau↓, *other↝, *lipid-P↓, *VitC↑, *antiOx↑,
4027- FulvicA,    Mummy Induces Apoptosis Through Inhibiting of Epithelial-Mesenchymal Transition (EMT) in Human Breast Cancer Cells
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, MCF-7 - in-vitro, Nor, MCF10
tumCV↓, selectivity↑, TGF-β↓, Twist↓, NOTCH1↓, CTNNB1↓, Src↓, E-cadherin↑, EMT↓, TumMeta↓, BioAv↑,

Showing Research Papers: 1 to 3 of 3

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3

Pathway results for Effect on Cancer / Diseased Cells:


Cell Death ⓘ

Apoptosis↑, 1,  

Transcription & Epigenetics ⓘ

other↝, 1,   tumCV↓, 3,  

Cell Cycle & Senescence ⓘ

TumCCA↑, 1,  

Proliferation, Differentiation & Cell State ⓘ

CTNNB1↓, 1,   EMT↓, 1,   NOTCH1↓, 1,   Src↓, 1,  

Migration ⓘ

E-cadherin↑, 1,   TGF-β↓, 1,   TumCMig↓, 1,   TumMeta↓, 1,   Twist↓, 1,   uPA↓, 1,  

Immune & Inflammatory Signaling ⓘ

CXCc↓, 1,  

Drug Metabolism & Resistance ⓘ

BioAv↑, 1,   Dose↝, 1,   selectivity↑, 3,  
Total Targets: 18

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress ⓘ

antiOx↑, 1,   lipid-P↓, 1,   VitC↑, 1,  

Transcription & Epigenetics ⓘ

other↝, 1,  

Synaptic & Neurotransmission ⓘ

tau↓, 1,  

Functional Outcomes ⓘ

memory↑, 1,   neuroP↑, 1,  
Total Targets: 7

Scientific Paper Hit Count for: selectivity, selectivity
3 Shilajit/Fulvic Acid
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:358  Target#:1110  State#:%  Dir#:2
  wNotes=0  sortOrder:rid,rpid

 

Home Page